Showing 1 - 4 results of 4 for search 'Chinyere Okoli', query time: 0.03s Refine Results
  1. 1
    Preference for non-daily ART is associated with perceived extent of ART-related emotional, psychosocial, physical, and adherence challenges among people living with HIV in the Netherlands and other European countries

    Preference for non-daily ART is associated with perceived extent of ART-related emotional, psychosocial, physical, and adherence challenges among people living with HIV in the Neth... by Reon van Dyk, Bart Lammertink, Ama Appiah, Hiskya Plieger, Patricia de los Rios, Chinyere Okoli

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Comorbidities, comedications and polypharmacy among people living with HIV and associated challenges with HIV antiretroviral therapy: Findings from people living with HIV in four countries in Western Europe

    Comorbidities, comedications and polypharmacy among people living with HIV and associated challenges with HIV antiretroviral therapy: Findings from people living with HIV in four c... by Chinyere Okoli, Laurent Finkielsztejn, Ama Appiah, Pascal Pugliese, Corinne V. Fructuoso, Patricia de los Rios

    Published 2022-07-01
    Get full text
    Article
  3. 3
    An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1

    An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimen... by Lee A. Evitt, Sakina Nanji, Richard A. Grove, Chinyere Okoli, Jean van Wyk, Sonya J. Snedecor

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies

    Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies... by Sharon Walmsley, Don E. Smith, Miguel Górgolas, Pedro E. Cahn, Thomas Lutz, Karine Lacombe, Princy N. Kumar, Brian Wynne, Richard Grove, Gilda Bontempo, Riya Moodley, Chinyere Okoli, Michelle Kisare, Bryn Jones, Andrew Clark, Mounir Ait-Khaled

    Published 2024-03-01
    Get full text
    Article

Search Tools: